Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsuedu.ru/handle/123456789/65885
Title: Correction of protein and lipid spectra of erythrocyte membranes as a pathogenetic supplement to the therapy of coronary heart disease
Authors: Dorofeeva, S. G.
Konoplya, E. N.
Mansimova, O. V.
Keywords: medicine
pharmacology
oxidative stress
cardiovascular diseases
clinical trial
Mexicor
antioxidant
Issue Date: 2025
Citation: Dorofeeva, S.G. Correction of protein and lipid spectra of erythrocyte membranes as a pathogenetic supplement to the therapy of coronary heart disease / S.G. Dorofeeva, E.N. Konoplya, O.V. Mansimova // Research Results in Pharmacology. - 2025. - Vol.11, №3.-P. 1-9. - Doi: 10.18413/rrpharmacology.11.718. - Refer.: p. 8.
Abstract: The drug Mexicor, which has antioxidant and endothelioprotective properties, is able to suppress oxidative stress and, therefore, restore the biochemical structure and gas exchange function of erythrocyte membranes, which can significantly complement traditional systems of therapy for cardiovascular diseases and CHD in particular
URI: http://dspace.bsuedu.ru/handle/123456789/65885
Appears in Collections:Vol. 11, № 3

Files in This Item:
File Description SizeFormat 
Dorofeeva_Correction_25.pdf848.19 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.